Virvio Company
Developer of a broadly-protective influenza therapeutic.
Technology:
Early Drug Development
Industry:
Early Drug Development
Headquarters:
Seattle, Washington, United States
Founded Date:
2015-12-01
Employees Number:
1-10
Investors Number:
1
Total Funding:
209000
Estimated Revenue:
Less than $1M
Last Funding Date:
2016-02-15
Last Funding Type:
Grant
Register and Claim Ownership